We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chicago, IL – March 16, 2026 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: https://www.zacks.com/stock/news/2884062/3-strong-buy-stocks-under-10)
3 Strong Buy Stocks Under $10
Welcome to Episode #477 of the Zacks Market Edge Podcast.
(1:00) - Where Can You Find Strong Investments For A Deal?
(5:45) - Tracey’s Top Stock Picks For Your Watchlist Right Now
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds, and ETFs and how it impacts your life.
In a prior podcast, Tracey looked at three stocks for your wish list but didn't realize that all three were stocks priced around $1000 per share. A listener commented in the YouTube comments that it was a bit too pricey for them.
Therefore, this week, Tracey looked for top ranked #1 stocks that were priced under $10.
Let's be honest, who doesn't like to buy a stock that is under $10? And if you can get it with analysts revising earnings estimates higher, even better.
Screening for Strong Buys Under $10
This is an easy screen. Originally, Tracey looked for Zacks #1 (Strong Buy) and #2 (Buy) stocks under $10, thinking there might not be that many stocks that matched that criteria but there were 155 stocks.
That is too big of a list.
Running it with just the #1 (Strong Buys) returned 17 stocks.
Several of them were foreign airlines. Given the Iran War and the concerns over the price of jet fuel, Tracey stayed away from those.
Chatham Lodging Trust invests in upscale, extended-stay hotels that are located in major markets. It owns 42 hotels in 15 states and Washington, DC. Some of their brands include the Embassy Suites, Courtyard, Residence Inn, and Homewood Suites. Chatham is a REIT.
On Mar 4, 2026, Chatham Lodging Trust acquired 6 new hotels and increased its quarterly dividend by 11%, or $0.10. That dividend is now yielding 4.6%.
Earnings are expected to rise 17.6% in 2026 and another 10% in 2027. Chatham Lodging Trust is dirt cheap, with a forward price-to-earnings (P/E) ratio of just 6.6.
Chatham Lodging is a Zacks #1 Rank (Strong Buy) stock.
InnovAge manages the care of high-cost, frail, dual-eligible seniors. The company's tag line is "Life on Your Terms" as it encourages seniors to age in their homes as long as possible. InnovAge has 8,010 participants across 20 centers in 6 states. It operates as an alternative to nursing facilities with customized healthcare and social support at nearby PACE centers.
Shares of InnovAge are up 60.5% year-to-date. Earnings are expected to rise 213% in fiscal 2026 and another 36% in fiscal 2027. InnovAge is a growth stock, with a forward P/E of 33.9.
InnovAge has now dropped to a Zacks #2 stock since the recording of the podcast. This is still a "Buy" stock.
Should investors look to healthcare stocks like InnovAge for their stocks under $10?
BCB Bancorp is the holding company for BCB Community Bank. It has 23 bank offices in New Jersey. In the fourth quarter of 2025, BCB Bancorp took a $12 million loss due to a pre-tax write-down of $15.1 million on a cannabis related property and a $16.3 million write-off in the bank's C&I loan portfolio. However, net interest margin ("NIM") was 3.03%, up from 2.88% in the third quarter of 2025.
Shares of BCB Bancorp have fallen 16.6% over the last year but are flat for 2026. Earnings are expected to turn around in 2026, jumping 234.5% to $1.13 from a loss of $0.84 in 2025.
BCB Bancorp is cheap. It trades with a price-to-book (P/B) ratio of just 0.5. Bank analysts look at P/B ratios for valuation. They buy at 1.0 and sell at 2.0. BCB Bancorp is even cheaper than that.
It's also shareholder friendly. BCB Bancorp pays a dividend of $0.32 annually, which is yielding 4%.
BCB Bancorp is a Zacks #1 Rank (Strong Buy).
Should a community bank like BCB Bancorp be on your short list?
What Else Should You Know About Strong Buys Under $10?
Tune into this week's podcast to find out.
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Zacks Market Edge Highlights: Chatham Lodging Trust, InnovAge and BCB Bancorp
For Immediate Release
Chicago, IL – March 16, 2026 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: https://www.zacks.com/stock/news/2884062/3-strong-buy-stocks-under-10)
3 Strong Buy Stocks Under $10
Welcome to Episode #477 of the Zacks Market Edge Podcast.
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds, and ETFs and how it impacts your life.
In a prior podcast, Tracey looked at three stocks for your wish list but didn't realize that all three were stocks priced around $1000 per share. A listener commented in the YouTube comments that it was a bit too pricey for them.
Therefore, this week, Tracey looked for top ranked #1 stocks that were priced under $10.
Let's be honest, who doesn't like to buy a stock that is under $10? And if you can get it with analysts revising earnings estimates higher, even better.
Screening for Strong Buys Under $10
This is an easy screen. Originally, Tracey looked for Zacks #1 (Strong Buy) and #2 (Buy) stocks under $10, thinking there might not be that many stocks that matched that criteria but there were 155 stocks.
That is too big of a list.
Running it with just the #1 (Strong Buys) returned 17 stocks.
Several of them were foreign airlines. Given the Iran War and the concerns over the price of jet fuel, Tracey stayed away from those.
3 Strong Buy Stocks Under $10
1. Chatham Lodging Trust (CLDT - Free Report)
Chatham Lodging Trust invests in upscale, extended-stay hotels that are located in major markets. It owns 42 hotels in 15 states and Washington, DC. Some of their brands include the Embassy Suites, Courtyard, Residence Inn, and Homewood Suites. Chatham is a REIT.
On Mar 4, 2026, Chatham Lodging Trust acquired 6 new hotels and increased its quarterly dividend by 11%, or $0.10. That dividend is now yielding 4.6%.
Earnings are expected to rise 17.6% in 2026 and another 10% in 2027. Chatham Lodging Trust is dirt cheap, with a forward price-to-earnings (P/E) ratio of just 6.6.
Chatham Lodging is a Zacks #1 Rank (Strong Buy) stock.
Should Chatham Lodging be on your short list?
2. InnovAge Holding Corp. (INNV - Free Report)
InnovAge manages the care of high-cost, frail, dual-eligible seniors. The company's tag line is "Life on Your Terms" as it encourages seniors to age in their homes as long as possible. InnovAge has 8,010 participants across 20 centers in 6 states. It operates as an alternative to nursing facilities with customized healthcare and social support at nearby PACE centers.
Shares of InnovAge are up 60.5% year-to-date. Earnings are expected to rise 213% in fiscal 2026 and another 36% in fiscal 2027. InnovAge is a growth stock, with a forward P/E of 33.9.
InnovAge has now dropped to a Zacks #2 stock since the recording of the podcast. This is still a "Buy" stock.
Should investors look to healthcare stocks like InnovAge for their stocks under $10?
3. BCB Bancorp, Inc. (BCBP - Free Report)
BCB Bancorp is the holding company for BCB Community Bank. It has 23 bank offices in New Jersey. In the fourth quarter of 2025, BCB Bancorp took a $12 million loss due to a pre-tax write-down of $15.1 million on a cannabis related property and a $16.3 million write-off in the bank's C&I loan portfolio. However, net interest margin ("NIM") was 3.03%, up from 2.88% in the third quarter of 2025.
Shares of BCB Bancorp have fallen 16.6% over the last year but are flat for 2026. Earnings are expected to turn around in 2026, jumping 234.5% to $1.13 from a loss of $0.84 in 2025.
BCB Bancorp is cheap. It trades with a price-to-book (P/B) ratio of just 0.5. Bank analysts look at P/B ratios for valuation. They buy at 1.0 and sell at 2.0. BCB Bancorp is even cheaper than that.
It's also shareholder friendly. BCB Bancorp pays a dividend of $0.32 annually, which is yielding 4%.
BCB Bancorp is a Zacks #1 Rank (Strong Buy).
Should a community bank like BCB Bancorp be on your short list?
What Else Should You Know About Strong Buys Under $10?
Tune into this week's podcast to find out.
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
Get all the details here >>
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch/
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/performance
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.